Article Text

Download PDFPDF
Clinical outcomes of potent antiplatelets compared with clopidogrel in ST elevation myocardial infarction

Statistics from Altmetric.com

Footnotes

  • Contributors SSN is the sole author of the editorial.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests SSN has received speaker honoraria from AstraZeneca and research funding from AstraZeneca.

  • Patient consent Not required.

  • Provenance and peer review Commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles